Close
Novotech
Jabsco PureFlo 21 Single Use

Press Releases

Merck and Orion Announce Global Collaboration for Oncology Drug

Merck, known as MSD outside the United States and Canada, and Orion Corporation are collaborating to develop and commercialize a treatment for metastatic castration-resistant prostate cancer. Merck, known as MSD outside the United States and Canada, announced a global development...

Tower Cold Chain Secures Further Investment to Supercharge its Success

Pharmaceutical temperature-controlled specialist Tower Cold Chain has secured £6.75million in investment, to reinforce the business as the leader in robust, reliable, and reusable cold chain solutions, following a period of rapid and sustained growth. The investment, backed by Investec, comes...

AARDEX® Group and BIOCORP Recruited by Trials@Home – Decentralized Clinical Trial Centre of Excellence

Following the launch of their global collaboration to support medication adherence in different fields last year, Belgium-based AARDEX GROUP, the leader in tools for measuring and managing adherence to medication in clinical trials, and French-based BIOCORP, the leader in...

Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m

Privately-owned Grünenthal estimates the Nebido brand will add about €100 million to its EBITDA in 2023. Grünenthal has agreed to acquire testosterone treatment NebidoTM and its associated brands from Bayer AG, for up to €500 million. The long-acting injectable treatment for...

Celegence acquires Qdossier to bolster its regulatory consultancy services and solutions for the pharmaceutical industry

Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has announced the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for pharmaceutical products. Qdossier also provides leading...

Symbiosis announces £1 million investment in analytical testing capability

Symbiosis Pharmaceutical Services (Symbiosis), an international contract manufacturing organisation (CMO) with headquarters in the UK, who specialise in providing GMP aseptic fill and finish services for biologic and small molecule pharmaceuticals to biotechnology and pharmaceutical companies worldwide, has announced...

Sustainable CDMO Samsung Biologics releases 2022 ESG Report

Samsung Biologics, the world’s leading contract development and manufacturing organization, published its second annual ESG Report, reflecting the company’s sustainability efforts in 2021 to address a wide range of environmental, social, and governance (ESG) activities related to its business....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »